Peto TEA - Search Results

1

Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom.

Wei J, Stoesser N, Matthews PC, Ayoubkhani D, Studley R, Bell I, Bell JI, Newton JN, Farrar J, Diamond I, Rourke E, Howarth A, Marsden BD, Hoosdally S, Jones EY, Stuart DI, Crook DW, Peto TEA, Pouwels KB, Eyre DW, Walker AS; COVID-19 Infection Survey team. Wei J, et al. Among authors: peto tea. Nat Microbiol. 2021 Sep;6(9):1140-1149. doi: 10.1038/s41564-021-00947-3. Epub 2021 Jul 21. Nat Microbiol. 2021. PMID: 34290390 Free PMC article. Clinical Trial.

2

Safe intravenous antibiotic therapy at home: experience of a UK based programme.

Kayley J, Berendt AR, Snelling MJ, Moore H, Hamilton HC, Peto TE, Crook DW, Conlon CP. Kayley J, et al. J Antimicrob Chemother. 1996 May;37(5):1023-9. doi: 10.1093/jac/37.5.1023. J Antimicrob Chemother. 1996. PMID: 8737154

3

Markers of HIV infection in the Concorde trial. Concorde Co-ordinating Committee.

Walker AS, Peto TE, Babiker AG, Darbyshire JH. Walker AS, et al. QJM. 1998 Jun;91(6):423-38. doi: 10.1093/qjmed/91.6.423. QJM. 1998. PMID: 9709461

4

Prospective evaluation of criteria for microbiological diagnosis of prosthetic-joint infection at revision arthroplasty. The OSIRIS Collaborative Study Group.

Atkins BL, Athanasou N, Deeks JJ, Crook DW, Simpson H, Peto TE, McLardy-Smith P, Berendt AR. Atkins BL, et al. J Clin Microbiol. 1998 Oct;36(10):2932-9. doi: 10.1128/JCM.36.10.2932-2939.1998. J Clin Microbiol. 1998. PMID: 9738046 Free PMC article.

5

Age as a determinant of survival in HIV infection.

Babiker AG, Peto T, Porter K, Walker AS, Darbyshire JH. Babiker AG, et al. J Clin Epidemiol. 2001 Dec;54 Suppl 1:S16-21. doi: 10.1016/s0895-4356(01)00456-5. J Clin Epidemiol. 2001. PMID: 11750205

6

Infectious disease training: challenges and opportunities.

Banatvala JE, Roberts C, Crook D, Peto T. Banatvala JE, et al. Lancet Infect Dis. 2002 Jan;2(1):9-10. doi: 10.1016/s1473-3099(01)00167-0. Lancet Infect Dis. 2002. PMID: 11892499 No abstract available.

7

Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential.

Brueggemann AB, Griffiths DT, Meats E, Peto T, Crook DW, Spratt BG. Brueggemann AB, et al. J Infect Dis. 2003 May 1;187(9):1424-32. doi: 10.1086/374624. Epub 2003 Apr 4. J Infect Dis. 2003. PMID: 12717624

8

Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children.

Brueggemann AB, Peto TE, Crook DW, Butler JC, Kristinsson KG, Spratt BG. Brueggemann AB, et al. J Infect Dis. 2004 Oct 1;190(7):1203-11. doi: 10.1086/423820. Epub 2004 Aug 25. J Infect Dis. 2004. PMID: 15346329

9

Acquisition of Streptococcus pneumoniae and nonspecific morbidity in infants and their families: a cohort study.

Sleeman KL, Daniels L, Gardiner M, Griffiths D, Deeks JJ, Dagan R, Gupta S, Moxon ER, Peto TE, Crook DW. Sleeman KL, et al. Pediatr Infect Dis J. 2005 Feb;24(2):121-7. doi: 10.1097/01.inf.0000151030.10159.b1. Pediatr Infect Dis J. 2005. PMID: 15702039

10

MRSA bacteraemia in patients on arrival in hospital: a cohort study in Oxfordshire 1997-2003.

Wyllie DH, Peto TE, Crook D. Wyllie DH, et al. BMJ. 2005 Oct 29;331(7523):992. doi: 10.1136/bmj.38558.453310.8F. Epub 2005 Sep 9. BMJ. 2005. PMID: 16155048 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

395 results

Search Page

Filters